(0 items)
Small Medium Large | Print-Friendly Version of this Page  | Email this Page to a Friend
Skip Navigation Links
Billing and Reimbursement Initiatives
Biovigilance
Consulting Services
Disaster Response
Global Services
National Blood Exchange
National Blood Foundation
NBF Scientific Research Grants Program
Scientific Research Grant Recipients/Scholars
NBF Grant Application Information for the 2014 NBF Grant Cycle
Opportunities to Partner with the National Blood Foundation
NBF Events at the 2013 AABB Annual Meeting in Denver
NBF Leadership Forum
2013 NBF Memorials and Tributes
NBF Board of Trustees for 2014
National Blood Foundation Staff
Donate to AABB/NBF
AABB > Programs & Services > National Blood Foundation > NBF Scientific Research Grants Program

NBF Scientific Research Grants Program 

Funds are raised annually from corporations, blood centers, foundations and individuals by the NBF for the National Blood Foundation Research and Education Trust Fund (NBFRET) and the NBF. The NBF and NBFRET, which are 501(c)(3) organizations, provide grants for scientific research in the field of transfusion medicine and cellular therapies and support educational initiatives that benefit this community. Since 1985, the NBF has distributed over $8 million to nearly 200 early-career scientists. The National Blood Foundation annually awards grants for one or two-year research projects, with a maximum award per grant of $75,000.

NBF Major Donors

NBF was founded with support from the NBF Council on Research and Development (CORD). CORD is comprised of companies and blood centers committed to supporting research in the field of transfusion medicine and cellular therapies. NBF thanks its CORD members for their financial support of the NBF Scientific Research Grants Program, as well as their representation and service on the NBF Board of Trustees. CORD members include the following organizations: Abbott Laboratories; American Red Cross; Blood Systems, Inc.; Cerus Corporation, Fenwal, Inc., A Fresenius Kabi Company; Haemonetics Corporation; ITxM-The Institute for Transfusion Medicine; New York Blood Center; Novartis Diagnostics and Terumo BCT.

The NBF Partners Program members, established in 2003, also play a critical role in supporting the mission of NBF. Current Partners include Blood Centers of America, Inc.; Beckman Coulter, Inc.; Blood Bank Computer Systems; Blood Bank of Delmarva; Blood Centers of the Pacific; BloodCenter of Wisconsin; Bonfils Blood Center; Canadian Blood Services; Group Services for America's Blood Centers; HemoCue America; Immucor, Inc.; LIFELINE Blood Services; LifeSouth Community Blood Centers; MacoPharma; Mediware Information Systems; Oklahoma Blood Institute; Puget Sound Blood Center; Rhode Island Blood Center and The Blood Alliance.

NBF is pleased to announce the availability of funding in 2014 for scientific research projects related to transfusion medicine and cellular therapies. NBF will award grants for investigator-initiated original research in all aspects of blood banking, transfusion medicine, cellular therapies and patient blood management.

Important areas of research for the grant program include:

IMMUNOLOGY

Alloimmunization, immune modulation, and tolerance
Animal models for the study of graft-vs-host disease
Biology of autoimmune hemolytic anemia

HEMATOLOGY

Autologous and allogeneic stem cell transplants
Detection of residual disease following stem cell transplants
Effects of growth factors in vitro and in vivo
Biochemistry of coagulation factors

IMMUNOHEMATOLOGY

Blood group serology
Biochemistry of red cell antigens
Molecular genetics of the blood groups

INFECTIOUS DISEASES

Studies on Lyme disease, West Nile Virus, SARS and babesiosis and other emerging diseases
Effect of allogeneic transfusion in HIV-infected and immunocompromised patients
Improved detection of transfusion - transmitted diseases

CELLULAR THERAPIES

Cell separation, cell culture or expansion studies for cell therapy applications
Development of novel cell therapies or assays to measure cell viability or function
Pilot studies in regenerative medicine
Studies on mechanisms or roles of cells in stem cell transplantation
Studies on cytokines or growth factors involved in stem cell differentiation

PATIENT BLOOD MANAGEMENT

Treatment of pre-admission anemia and bleeding tendencies; Intraoperative/postoperative blood recovery; Surgical hemostasis; Appropriate indications for transfusion; Changing physician behaviors; Blood utilization review.

Grants applications are evaluated on the basis of their scientific merit, relevance to and impact on transfusion medicine, focus and appropriateness to the scope of funding, and likelihood of yielding meaningful data.

Eligibility Requirements

  • An applicant must be a doctor (MD or PhD), medical technologist, transfusion medicine or cellular therapies professional. All applicants will be considered regardless of age, race, gender, national origin or religion.
  • The NBF accepts national and international applicants who are ideally no more than five years post-doctoral training.
  • Applications for research into innovative and new projects are a priority.
  • Emphasis is given to applicants who have not previously received an NBF grant.
  • No candidate is eligible to receive more than two NBF grants for separate projects.
  • No particular project can be funded more than once.
  • An application for the same project may be submitted up to three times if not already NBF funded.
  • Awards will not be made to increase the funding available for currently funded research projects. NBF grants are intended to provide "seed" funding that allows the principal investigator to enhance preliminary data. This data may then be useful in applying for larger grants.

 Resources

Home  |  Site Map  | AABB © 2014. All rights reserved. |  Privacy Statement  |  Terms of Use